Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
September 21, 2016 at 07:21 AM EDT
Allergan plc Ordinary Shares (NYSE: AGN) paid a hefty premium of 159 percent to acquire Vitae Pharmaceuticals Inc (NASDAQ: VTAE) last ...